These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 28792089)
41. Elevations in skin tissue levels of bile acids in human cholestasis: relation to serum levels and topruritus. Ghent CN; Bloomer JR; Klatskin G Gastroenterology; 1977 Nov; 73(5):1125-30. PubMed ID: 908491 [TBL] [Abstract][Full Text] [Related]
43. Plasmaperfusion for the treatment of intractable pruritus of cholestasis. Lauterburg BH; Pineda AA; Dickson ER; Baldus WP; Taswell HF Mayo Clin Proc; 1978 Jun; 53(6):403-7. PubMed ID: 651386 [TBL] [Abstract][Full Text] [Related]
44. Care of the cholestatic patient. Gossard AA Clin Liver Dis; 2013 May; 17(2):331-44. PubMed ID: 23540506 [TBL] [Abstract][Full Text] [Related]
45. Blood cytokine, chemokine and gene expression in cholestasis patients with intractable pruritis treated with a molecular adsorbent recirculating system: a case series. Lisboa LF; Asthana S; Kremer A; Swain M; Bagshaw SM; Gibney N; Karvellas CJ Can J Gastroenterol; 2012 Nov; 26(11):799-805. PubMed ID: 23166903 [TBL] [Abstract][Full Text] [Related]
46. The pruritus of cholestasis: From bile acids to opiate agonists: Relevant after all these years. Bergasa NV Med Hypotheses; 2018 Jan; 110():86-89. PubMed ID: 29317077 [TBL] [Abstract][Full Text] [Related]
47. [Studies on pruritus in obstructive jaundice cases with special references to serum bile acid fractions]. Mashima H Fukuoka Igaku Zasshi; 1991 Aug; 82(8):445-57. PubMed ID: 1937344 [TBL] [Abstract][Full Text] [Related]
48. Cholestatic liver disease. Gossard AA; Talwalkar JA Med Clin North Am; 2014 Jan; 98(1):73-85. PubMed ID: 24266915 [TBL] [Abstract][Full Text] [Related]
49. An approach to the management of the pruritus of cholestasis. Bergasa NV Clin Liver Dis; 2004 Feb; 8(1):55-66, vi. PubMed ID: 15062193 [TBL] [Abstract][Full Text] [Related]
50. Treatment of refractory cholestatic pruritus with molecular adsorbent recirculating system (MARS). Montero JL; Pozo JC; Barrera P; Fraga E; Costán G; Domínguez JL; Muntané J; Rodriguez-Ariza A; Pleguezuelo M; Rufián S; López-Cillero P; de la Mata M Transplant Proc; 2006 Oct; 38(8):2511-3. PubMed ID: 17097984 [TBL] [Abstract][Full Text] [Related]
51. Intensive plasmapheresis as an alternative therapy for intractable pruritus of primary biliary cirrhosis. Kohan AI; Findor JA; Igartua EB; Villaravid N Transfus Sci; 1991; 12(3):197-200. PubMed ID: 10149548 [TBL] [Abstract][Full Text] [Related]
52. The Investigation of Therapeutic Implications of Mast Cell Stabilizer Cromolyn Sodium on Cholestasis and Cholestatic Pruritus in Experimental Cholestasis. Yurdakul Ertan H; Özbakış Dengiz G; Barut F; Yılmaz Ürün Y; Can M; Hussen SU; Üstündağ Y Turk J Gastroenterol; 2023 Jan; 34(1):62-72. PubMed ID: 36098363 [TBL] [Abstract][Full Text] [Related]
53. Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions. Kremer AE; van Dijk R; Leckie P; Schaap FG; Kuiper EM; Mettang T; Reiners KS; Raap U; van Buuren HR; van Erpecum KJ; Davies NA; Rust C; Engert A; Jalan R; Oude Elferink RP; Beuers U Hepatology; 2012 Oct; 56(4):1391-400. PubMed ID: 22473838 [TBL] [Abstract][Full Text] [Related]
54. Partial external biliary diversion in children with progressive familial intrahepatic cholestasis and Alagille disease. Yang H; Porte RJ; Verkade HJ; De Langen ZJ; Hulscher JB J Pediatr Gastroenterol Nutr; 2009 Aug; 49(2):216-21. PubMed ID: 19561545 [TBL] [Abstract][Full Text] [Related]
55. Pruritus of unknown origin and elevated total serum bile acid levels in patients without clinically apparent liver disease. Eisendle K; Müller H; Ortner E; Talasz H; Graziadei I; Vogel W; Höpfl R J Gastroenterol Hepatol; 2011 Apr; 26(4):716-21. PubMed ID: 21155876 [TBL] [Abstract][Full Text] [Related]
57. Evaluation of the role of bile acids and serotonin as markers of pruritus in children with chronic cholestatic liver disease. Koofy NE; Yassin N; Okasha S; William H; Elakel W; Elshiwy Y Arab J Gastroenterol; 2021 Sep; 22(3):199-202. PubMed ID: 34090830 [TBL] [Abstract][Full Text] [Related]
58. Safety and efficacy of long-term nasobiliary drainage to treat intractable pruritus in cholestatic liver disease. Appleby VJ; Hutchinson JM; Davies MH Frontline Gastroenterol; 2015 Oct; 6(4):252-254. PubMed ID: 28839819 [TBL] [Abstract][Full Text] [Related]
59. Effect of molecular adsorbent recirculating system in hepatitis C virus-related intractable pruritus. Doria C; Mandalá L; Smith J; Vitale CH; Lauro A; Gruttadauria S; Marino IR; Foglieni CS; Magnone M; Scott VL Liver Transpl; 2003 Apr; 9(4):437-43. PubMed ID: 12682899 [TBL] [Abstract][Full Text] [Related]
60. Charcoal hemoperfusion in the treatment of medically refractory pruritus in cholestatic liver disease. Kittanamongkolchai W; El-Zoghby ZM; Eileen Hay J; Wiesner RH; Kamath PS; LaRusso NF; Watt KD; Cramer CH; Leung N Hepatol Int; 2017 Jul; 11(4):384-389. PubMed ID: 27933591 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]